Biblio Discovery — Demo Discovery Service

114 results for "Cohn, Susan L."

Showing 1–20 · 0.70 seconds · RSS

  1. Journal Article Full text

    Diagnosis and Classification of the Small Round-Cell Tumors of Childhood

    Cohn, Susan L.

    Am J Pathol · 1999 · English · PubMed Central

  2. Journal Article Full text

    Genetic Discoveries and Treatment Advances in Neuroblastoma

    Bagatell, Rochelle; Cohn, Susan L.

    Curr Opin Pediatr · 2016 · English · PubMed Central

    PURPOSE OF REVIEW: Major advances in our understanding of the genetic basis of neuroblastoma and the role somatic alterations play in driving tumor growth have led to improvements in risk-stratified therapy and have provided the rationale for targeted therapies. In this review, we highlight current…

  3. Journal Article Full text

    Using Germline Genomics to Individualize Pediatric Cancer Treatments

    Pinto, Navin; Cohn, Susan L; Dolan, M. Eileen

    Clin Cancer Res · 2012 · English · PubMed Central

    The amazing successes in cure rates for children with cancer over the last century have come in large part from identifying clinical, genetic and molecular variables associated with response to therapy in large cooperative clinical trials and stratifying therapies according to the predicted risk of…

  4. Journal Article Full text

    New Aspects of Neuroblastoma Treatment: ASPHO 2011 Symposium Review

    Zage, Peter E.; Louis, Chrystal U.; Cohn, Susan L.

    Pediatr Blood Cancer · 2012 · English · PubMed Central

    Neuroblastoma is the most common extracranial solid tumor of childhood, and the outcomes for children with high-risk and relapsed disease remain poor. However, new international strategies for risk stratification and for treatment based on novel tumor targets and including immunotherapy are being…

  5. Journal Article Full text

    Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient

    Gerstle, Karyn; Siddiqui, Amir; Schulte, Jefree J. et al.

    Pediatr Blood Cancer · 2020 · English · PubMed Central

    Opsoclonus myoclonus syndrome (OMS) is a rare neurological syndrome caused by a paraneoplastic autoimmune process that affects children with neuroblastic tumors. Treatment includes corticosteroids, intravenous gamma globulin (IVIG), rituximab, and other immunosuppressive therapies. Here, we…

  6. Journal Article Full text

    Emerging and investigational therapies for neuroblastoma

    Applebaum, Mark A.; Desai, Ami V.; Glade Bender, Julia L. et al.

    Expert Opin Orphan Drugs · 2017 · English · PubMed Central

    INTRODUCTION: Treatment for children with clinically aggressive, high-risk neuroblastoma remains challenging. Less than 50% of patients with high-risk neuroblastoma will survive long-term with current therapies, and survivors are at risk for serious treatment-related late toxicities. Here, we…

  7. Journal Article Full text

    Association Between End-Induction Response According to the Revised International Neuroblastoma Response Criteria (INRC) and Outcome in High-Risk Neuroblastoma Patients

    Barr, Erin K.; Laurie, Kathryn; Wroblewski, Kristen et al.

    Pediatr Blood Cancer · 2020 · English · PubMed Central

    BACKGROUND: The 1993 International Neuroblastoma Response Criteria (INRC) were revised in 2017 to include modern functional imaging studies and methods for quantifying disease in bone marrow. We hypothesized the 2017 INRC would enable more precise assessment of response to treatment and provide…

  8. Journal Article Full text

    Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System

    Naranjo, Arlene; Irwin, Meredith S.; Hogarty, Michael D. et al.

    JCO Clin Cancer Inform · 2018 · English · PubMed Central

    PURPOSE: The International Neuroblastoma Risk Group (INRG) Staging System (INRGSS) was developed through international consensus to provide a presurgical staging system that uses clinical and imaging data at diagnosis. A revised Children's Oncology Group (COG) neuroblastoma (NB) risk classification…

  9. Journal Article Full text

    Second Malignancies in Patients with Neuroblastoma: The Effects of Risk-Based Therapy

    Applebaum, Mark A.; Henderson, Tara O.; Lee, Sang Mee et al.

    Pediatr Blood Cancer · 2014 · English · PubMed Central

    BACKGROUND: To investigate the incidence of second malignant neoplasms (SMN) for patients with neuroblastoma, we analyzed patients from the SEER database according to three treatment eras (1: 1973–1989, 2: 1990–1996, 3: 1997–2006) corresponding to the introduction of multi-agent chemotherapy…

  10. Journal Article Full text

    The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy

    Secola, Rita; Marachelian, Araz; Cohn, Susan L. et al.

    J Pediatr Oncol Nurs · 2017 · English · PubMed Central

    Neuroblastoma, an embryonic cancer of the sympathetic nervous system, is the most common extracranial solid tumor in childhood. Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with…

  11. Journal Article

    Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

    Salwen Helen R; Guerrero Lisa J; Chlenski Alexandre et al.

    BMC Cancer, Vol. 10 No. 1 · 2010 · English · DOAJ Scopus

    Abstract Background Epigenetic aberrations and a CpG island methylator phenotype have been shown to be associated with poor outcomes in children with neuroblastoma (NB). Seven cancer related genes (THBS-1, CASP8, HIN-1, TIG-1, BLU, SPARC, and HIC-1) that have been shown to have epigenetic changes…

  12. Journal Article Full text

    Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors

    Zeine, Rana; Salwen, Helen R; Peddinti, Radhika et al.

    Mod Pathol · 2009 · English · PubMed Central

    Stromal cells play a central role in the regulation of tumor angiogenesis. Recent studies have shown that stromal myofibroblasts [cancer-associated fibroblasts] actively promote tumor growth and enhance tumor angiogenesis in many types of adult carcinomas. To evaluate the role cancer-associated…

  13. Journal Article Full text

    Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts

    Liu, Shuqing; Tian, Yufeng; Chlenski, Alexandre et al.

    Am J Pathol · 2005 · English · PubMed Central

    Neuroblastoma (NB) tumors with abundant schwannian stroma have a differentiated phenotype, low vascularity, and are associated with a favorable prognosis. These observations suggest that cross-talk between Schwann cells and neuroblasts may influence tumor biology. To test this hypothesis, we…

  14. Journal Article

    Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

    Tian Yufeng; Yang Qiwei; Leonhardt Payton T et al.

    Molecular Cancer, Vol. 9 No. 1 · 2010 · English · DOAJ Scopus

    Abstract Background New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein Acidic and Rich in Cysteine (SPARC) and a SPARC peptide corresponding to the follistatin domain of the protein (FS-E)…

  15. Journal Article Full text

    Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study

    Henderson, Tara O.; Bhatia, Smita; Pinto, Navin et al.

    J Clin Oncol · 2010 · English · PubMed Central

    PURPOSE: Although health disparities are well-described for many cancers, little is known about racial and ethnic disparities in neuroblastoma. To evaluate differences in disease presentation and survival by race and ethnicity, data from the Children's Oncology Group (COG) were analyzed. PATIENTS…

  16. Journal Article Full text

    Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

    Chen, Lindi; Humphreys, Angharad; Turnbull, Lisa et al.

    Oncotarget · 2016 · English · PubMed Central

    Anaplastic Lymphoma Kinase (ALK) is a transmembrane receptor kinase that belongs to the insulin receptor superfamily and has previously been shown to play a role in cell proliferation, migration and invasion in neuroblastoma. Activating ALK mutations are reported in both hereditary and sporadic…

  17. Journal Article Full text

    MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia

    Hains, Anastasia E.; Uppal, Sakshi; Cao, John Z. et al.

    Epigenetics · 2022 · English · PubMed Central

    Ten-Eleven-Translocation 5-methylcytosine dioxygenases 1–3 (TET1-3) convert 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC), using oxygen as a co-substrate. Contrary to expectations, hypoxia induces 5-hmC gains in MYCN-amplified neuroblastoma (NB) cells via upregulation of TET1. Here, we show…